Non-equivalence based therapies are a type of behavioral therapy that is based on the principle of non-reinforcement. This means that the therapist does not reinforce the target behavior, but instead ignores it. The goal of non-equivalence based therapies is to reduce the frequency of the target behavior by making it less rewarding.

Ethical implications

There are a number of ethical implications for ABAs implementing non-equivalence based therapies. One of the most important ethical considerations is the potential for harm to the client. Non-reinforcement can lead to an increase in the frequency of the target behavior, as well as to frustration and anxiety. ABAs must carefully consider the potential risks and benefits of non-equivalence based therapies before implementing them.

Another ethical consideration is the client’s right to informed consent. ABAs must obtain the client’s (or the client’s guardian’s) informed consent before implementing non-equivalence based therapies. This means that the client (or the guardian) must be fully informed about the risks and benefits of the therapy before agreeing to participate.

Finally, ABAs must be aware of the ethical guidelines that govern the use of non-equivalence based therapies. The Ethics Code for Behavior Analysts (2004) specifically prohibits the use of non-reinforcement in a way that is “degrading, aversive, or punitive.” ABAs must ensure that they are using non-equivalence based therapies in a way that is ethical and respectful of the client.

Course materials

The course materials that I have read discuss the ethical implications of non-equivalence based therapies in detail. For example, the book “Behavior Modification: Principles and Procedures” (Cooper, Heron, & Heward, 2007) states that “non-reinforcement should only be used when other methods have been unsuccessful or when the target behavior is dangerous or harmful.” The book also emphasizes the importance of obtaining informed consent before implementing non-equivalence based therapies.

Ethics Code for Behavior Analysts

The Ethics Code for Behavior Analysts (2004) specifically addresses the use of non-reinforcement in Section 3.03, “Avoidance of Harmful Conditions.” This section states that “behavior analysts must not use procedures that are likely to cause harm or that are excessive in the amount of harm they may cause.” The section also states that “behavior analysts must take steps to minimize the possibility of harm to clients or research participants.”

Conclusion

The ethical implications of non-equivalence based therapies are complex and must be carefully considered by ABAs before implementing these therapies. ABAs must weigh the potential risks and benefits of non-equivalence based therapies and ensure that they are using these therapies in a way that is ethical and respectful of the client.